ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
ORTX
Delisted
ORTX was delisted on the 23rd of January, 2024.
32 hedge funds and large institutions have $46.9M invested in Orchard Therapeutics plc American Depositary Shares in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Holders
32
Holding in Top 10
1
Calls
$153K
Puts
$21K
Top Buyers
| 1 | +$13.2M | |
| 2 | +$2.79M | |
| 3 | +$292K | |
| 4 |
FA
Forefront Analytics
West Conshohocken,
Pennsylvania
|
+$110K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$104K |
Top Sellers
| 1 | -$1.84M | |
| 2 | -$235K | |
| 3 | -$148K | |
| 4 |
Morgan Stanley
New York
|
-$110K |
| 5 |
JPMorgan Chase & Co
New York
|
-$93.2K |